Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20051
20061
20074
20081
20101
20111
20121
20151
20161
20172
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec2
AstraZeneca1
Boehringer Ingelheim1
Brigham and Women's Hospital1
Canadian Heart Research Centre1
Cardiology Research UBC1
Eli Lilly and Company1
Hamilton Health Sciences Corporation1
KU Leuven1
Lantheus Medical Imaging1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction22
Stroke7
Cardiovascular Diseases5
Acute Coronary Syndrome2
Aortic Valve Disease2
Coronary Artery Disease2
Heart Diseases2
Heart Failure2
Hemorrhage2
Hypertension2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.